Bullfrog AI (NASDAQ:BFRG) leverages advanced artificial intelligence technologies to revolutionize how clinical trials are approached, aiming to significantly improve the speed and efficiency of bringing new medical treatments to market. The company specializes in utilizing machine learning algorithms to analyze vast datasets, helping to predict outcomes and optimize patient selection for clinical studies. Bullfrog AI's projects focus on reducing the time and costs associated with drug development, while aiming to increase the success rate of clinical trials. Their objective is to harness the power of AI to make the drug development process more efficient, accurate, and accessible, ultimately leading to faster delivery of safe and effective therapies to those in need.